UK markets close in 4 hours 44 minutes
  • FTSE 100

    7,125.14
    +48.97 (+0.69%)
     
  • FTSE 250

    22,711.35
    +219.99 (+0.98%)
     
  • AIM

    1,256.08
    +3.39 (+0.27%)
     
  • GBP/EUR

    1.1526
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.3918
    +0.0026 (+0.19%)
     
  • BTC-GBP

    40,618.10
    -1,355.57 (-3.23%)
     
  • CMC Crypto 200

    1,473.66
    +2.24 (+0.15%)
     
  • S&P 500

    4,201.62
    +34.03 (+0.82%)
     
  • DOW

    34,548.53
    +318.19 (+0.93%)
     
  • CRUDE OIL

    64.66
    -0.05 (-0.08%)
     
  • GOLD FUTURES

    1,821.40
    +5.70 (+0.31%)
     
  • NIKKEI 225

    29,357.82
    +26.45 (+0.09%)
     
  • HANG SENG

    28,610.65
    -26.81 (-0.09%)
     
  • DAX

    15,385.96
    +189.22 (+1.25%)
     
  • CAC 40

    6,373.98
    +16.89 (+0.27%)
     

French medical academy wants to wait six months between Covid jabs

·2-min read

France's Academy of Medicine has called for the delay between doses of the Covid-19 vaccine to be extended from six weeks to six months, in the case of the Pfizer and Moderna injections, in order to allow more people to get the first jab.

Pushing the second injection back in the under-55 age bracket would "accelerate the vaccination campaign...and achieve herd immunity much faster with the same number of doses, while ensuring satisfactory individual protection", the National Academy of Medicine said in a statement on Thursday.

The academy has no decision-making power in France, unlike the High Authority for Health (HAS), which can make such recommendations with the backing of the government.

On Wednesday, the delay between the first two doses of the Pfizer/BioNTech and Moderna vaccines, which use new messenger RNA technology, was extended from 4 to six weeks.

"This will allow us to speed up the vaccination campaign without compromising public protection," Health Minister Olivier Véran explained to French weekly Journal du Dimanche.

High-risk professions

The Academy of Medicine said that, based on recent studies in the United States and United Kingdom, a single dose of the mRNA vaccine had been shown to provide very high level of protection against the coronavirus.

With the more contagious British variant now the dominant strain in France, the academy said it made sense to delay second injections for those aged under 55 years with no history of immune deficiency, to allow more people in high-risk professions, such as teachers, to receive their first dose.

In France, the only under-55s currently eligible for the vaccination are frontline priority workers (health workers, home care workers, firefighters) or those with pre-existing health conditions.

Some scientists are reluctant to extend the delay between doses, fearing incomplete protection provided by the first injection may favour the emergence of new variants.

The academy also called for the first injection to be postponed in the case of patients who had tested positive for the coronavirus within the preceding six months.